Key Takeaways
- Herbalife Expands Personalized Nutrition: The acquisition of Bioniq for $55 million strengthens Herbalife's position in customized supplement formulas.
- Arginine Shows Promise for Alzheimer's: New research from Kindai University indicates the amino acid arginine can reduce toxic amyloid-beta protein buildup.
- Creatine Goes Mainstream: Projected to exceed $700 million by 2028, creatine is expanding beyond sports nutrition into cognitive health and healthy aging.
- GLP-1 Companion Supplements Rise: Force Factor's launch of Super GLP-1 Support Formulas highlights the growing trend of botanical solutions for weight management.
- Regulatory Shifts in India: The FSSAI's ban on ashwagandha leaves in supplements has sparked industry-wide discussions on supply chain transparency.
Top Stories
Herbalife has announced a definitive agreement to acquire the personalized supplement assets of UK-based Bioniq for $55 million. This strategic acquisition significantly expands Herbalife's capabilities in the rapidly growing personalized nutrition sector. Bioniq utilizes patented technology to develop customized supplement formulas based on individual health data. The transaction, expected to close in the second quarter of 2026, complements Herbalife's previous acquisitions of Pro2col and Link BioSciences, further solidifying its position in the personalized wellness market. Source
In a major development for the cognitive health sector, researchers at Kindai University have discovered that the common amino acid arginine can significantly reduce the buildup of toxic amyloid-beta proteins associated with Alzheimer's disease. Published in Neurochemistry International, the study demonstrates that arginine acts as a safe chemical chaperone, suppressing protein aggregation both in vitro and in vivo. Given that arginine is already established as clinically safe and inexpensive, researchers highlight its strong potential for repositioning as an accessible therapeutic option for cognitive decline, a focus area for products like our Lion's Mane mushroom extract. Source
The National Animal Supplement Council (NASC) has proposed the Animal Health Supplement Act, aiming to establish a statutory category for animal health supplements under U.S. law. This legislative framework seeks to replace current regulatory uncertainty with a transparent system for ingredient review, structure/function claims, and adverse event reporting. By treating these products as food rather than unapproved drugs, the bill aims to reduce the fragmentation caused by varying state regulations while providing the FDA with a clearer framework for industry oversight. Source
Business & Investment
Cabaletta Bio has announced the pricing of a $150 million underwritten offering of common stock, with participation from major players including Eli Lilly and Company. The clinical-stage biotechnology company will utilize the funds to advance its development of targeted cell therapies for autoimmune diseases, highlighting continued strong investment in advanced therapeutic interventions. Source
UK-based Croda International Plc has reinforced its presence in the active ingredients market through the $263 million acquisition of South Korea's Solus Biotech Co., Ltd. This strategic move expands Croda's biotechnology portfolio, particularly in the areas of ceramides and phospholipids, which are increasingly utilized in both pharmaceutical and advanced beauty care applications. Source
Science & Research
A new network meta-analysis has provided comparative insights into adjunctive treatments for major depressive disorder (MDD). The analysis found that Johnson & Johnson's CAPLYTA® (lumateperone) ranked highest among FDA-approved adjunctive therapies across four key efficacy measures. Notably, the treatment demonstrated no statistically significant weight gain compared to placebo, offering valuable data for clinical decision-making in the absence of head-to-head trials. Source
Recent research continues to validate the efficacy of branded botanical ingredients. A new study demonstrates that Digexin, a proprietary blend of ashwagandha and okra extracts developed by NXT USA, improves butyrate production and promotes healthy microbial cross-feeding in the gut. Additionally, a comprehensive meta-analysis on Rhodiola rosea supplementation has reinforced its ergogenic benefits for endurance performance. Source
New Product Launches & Formulation
Force Factor has expanded the growing GLP-1 companion supplement category with the launch of its Super GLP-1 Support Formulas. The new product line features Eriomin, a clinically backed ingredient designed to support metabolism, weight management, and healthy blood sugar levels. The launch reflects the industry's rapid response to the rising consumer demand for botanical solutions that complement or mimic the effects of GLP-1 weight loss medications. Source
Haleon has introduced a newly reformulated version of its Centrum Adults 50+ Complete Multivitamin. The updated formulation is now clinically shown to support memory and brain health, addressing the specific cognitive and nutritional needs of the aging demographic. This launch underscores the broader industry trend of incorporating targeted cognitive support into foundational daily nutrition products. Source
Solaray has launched what it claims to be the first fully liposomal prenatal vitamin on the market. The formulation utilizes fat-encapsulated nutrients designed to enhance absorption and ensure gentle digestion, addressing common consumer complaints regarding the tolerability of traditional prenatal supplements. Source
Regulations & Quality
The Food Safety and Standards Authority of India (FSSAI) has issued a directive banning the use of ashwagandha leaves in health supplements, permitting only the roots and their extracts. This regulatory action has prompted mixed responses from the natural products industry, sparking discussions regarding safety data, supply chain transparency, and the potential impact on global botanical sourcing. Organizations including the American Herbal Products Association (AHPA) are actively monitoring the situation. Source
The BSCG Certified GMP program has expanded its offerings to provide verification of Good Manufacturing Practices compliance at both the brand and product levels. This development addresses a significant gap in the industry, where most certifications previously only covered manufacturing facilities. The new seal allows consumer packaged goods brands to demonstrate verified third-party adherence to quality control protocols directly to consumers. Source
Marketing & Consumer Trends
The global market for stress relief supplements is projected to reach $1.14 billion by 2036, growing at a compound annual growth rate of 5.5%. According to Future Market Insights, this expansion is primarily driven by increasing mental health awareness and a strong consumer preference for non-pharmaceutical, plant-based formulations. Ingredients such as ashwagandha, L-theanine, and rhodiola are leading this category growth, similar to the synergistic blend found in our CALM stress support formula. Source
Creatine is successfully transitioning from a niche sports nutrition ingredient to a mainstream health and wellness staple, which is why we offer a pure Creatine Monohydrate for optimal absorption. With sales projected to exceed $700 million by 2028, the ingredient is finding new applications in cognitive health, healthy aging, and women's life stages. Formulators are increasingly pairing creatine with synergistic ingredients like HMB and alpha-lipoic acid, while exploring novel delivery formats such as gummies to reach broader consumer demographics. Source